SCHEMBL6171706

SCHEMBL6171706

Cc1csc(-c2noc(C)c2-c2ccc(S(N)(=O)=O)cc2)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 15/20 0.62
CA1 P00915 4/20 0.62
CA2 P00918 4/20 0.62
MT-CO2 P00403 3/20 0.62
PTGS1 P23219 3/20 0.62
CA12 O43570 3/20 0.62
CA9 Q16790 3/20 0.62
CA4 P22748 2/20 0.62
CA7 P43166 2/20 0.62
LMNA P02545 1/20 0.62
CA3 P07451 1/20 0.62
ADRB2 P07550 1/20 0.62
ADRB1 P08588 1/20 0.62
CYP3A4 P08684 1/20 0.62
ADORA3 P0DMS8 1/20 0.62
CHRM1 P11229 1/20 0.62
ADRA2B P18089 1/20 0.62
CA6 P23280 1/20 0.62
SLC6A2 P23975 1/20 0.62
PDE4A P27815 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6516284 0.81 PTGS2 (0.43) PTGS2CA1CA2MT-CO2PTGS1
SCHEMBL6170420 0.80 PTGS2 (0.82) PTGS2CA1CA2MT-CO2PTGS1
SCHEMBL8477628 0.80 PTGS2 (0.43) PTGS2CA1CA2MT-CO2PTGS1
SCHEMBL31213504 0.79 PTGS2 (0.78) PTGS2CA1CA2MT-CO2PTGS1
SCHEMBL6168350 0.78 PTGS2 (0.78) PTGS2CA1CA2MT-CO2PTGS1
Valdecoxib SCHEMBL3356 0.77 PTGS2 (1.00) PTGS2CA1CA2MT-CO2PTGS1
SCHEMBL6168344 0.77 PTGS2 (1.00) PTGS2CA1CA2MT-CO2PTGS1
Valdecoxib SCHEMBL3853130 0.77 PTGS2 (1.00) PTGS2CA1CA2MT-CO2PTGS1
SCHEMBL28397844 0.76 PTGS2 (0.78) PTGS2CA1CA2MT-CO2PTGS1
SCHEMBL6169904 0.76 PTGS2 (0.81) PTGS2CA1CA2MT-CO2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1528059-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle LLC (US) 2005-05-04 EP disclosed
EP-1223167-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle & Co. (US) 2002-07-17 EP disclosed
US-5985902-A TREATING INFLAMMATION AND INFLAMMATION-ASSOCIATED DISORDERS, SUCH AS ARTHRITIS G.D. SEARLE & CO. (US) 1999-11-16 US disclosed
EP-0809636-A1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-12-03 EP disclosed
US-5633272-A Substituted isoxazoles for the treatment of inflammation PHARMACIA & UPJOHN COMPANY LLC 1997-05-27 US disclosed
WO-1996025405-A1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-08-22 WO disclosed